help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chin, W. W.
Right arrow Articles by Ridgway, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chin, W. W.
Right arrow Articles by Ridgway, E. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LEVOTHYROXINE
*LIOTHYRONINE

Endocrinology, Vol 116, 873-878, Copyright © 1985 by Endocrine Society


ARTICLES

Regulation of the alpha and thyrotropin beta-subunit messenger ribonucleic acids by thyroid hormones

WW Chin, MA Shupnik, DS Ross, JF Habener and EC Ridgway

We studied the regulation of mRNAs encoding the alpha- and beta- subunits of TSH by thyroid hormones (T4 and T3) in mouse thyrotropic tumors and pituitary glands. Hypothyroid male (LAF1) mice bearing thyrotropic tumor (TtT97) were injected daily with T4 for 0, 1, 5, 12, or 33 days. After day 33, plasma levels of TSH and free (unassociated) TSH beta-subunit were reduced to less than 1% of control levels, whereas free alpha-subunit was reduced to 6% of control levels. Steady state levels of subunit mRNAs in extracts of the thyrotropic tissues were measured by blot hybridization analyses using mouse subunit- specific cloned cDNAs. Treatment of mice with T4 caused a rapid decline in the levels of tumor mRNAs for both alpha and TSH beta; after day 1, alpha and TSH beta mRNA levels decreased to 35% and 10% of control values, respectively. Levels of TSH beta mRNA were undetectable after 5 days of T4 treatment, whereas levels of alpha-subunit mRNA remained at 30-35% of control levels even after day 33. In a separate experiment, TSH beta mRNA decreased to 42% of the control level (P less than 0.05), whereas alpha-subunit mRNA remained at 64% of the control level (P = NS) 4 h after a single injection of T4. Finally, T3 also caused a rapid decrease in the levels of both subunit mRNAs in the anterior pituitary glands of hypothyroid mice, but the effect was more complete on TSH beta mRNA levels. We conclude that thyroid hormones have rapid suppressive effects on the levels of mRNAs encoding the subunits of mouse TSH in the thyrotrope. The suppressive effects of thyroid hormones occur more rapidly and are greater for TSH beta than alpha- subunit mRNAs. The parallel changes observed in the subunit mRNA levels and the plasma subunit protein levels in animals treated with thyroid hormones suggest that the changes in the plasma levels of TSH and subunits may reflect effects of thyroid hormones on TSH gene expression in addition to effects on secretion.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
D. F. Gordon, E. A. Tucker, K. Tundwal, H. Hall, W. M. Wood, and E. C. Ridgway
MED220/Thyroid Receptor-Associated Protein 220 Functions as a Transcriptional Coactivator with Pit-1 and GATA-2 on the Thyrotropin-{beta} Promoter in Thyrotropes
Mol. Endocrinol., May 1, 2006; 20(5): 1073 - 1089.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Friedrichsen, S. Christ, H. Heuer, M. K. H. Schafer, A. F. Parlow, T. J. Visser, and K. Bauer
Expression of Pituitary Hormones in the Pax8-/- Mouse Model of Congenital Hypothyroidism
Endocrinology, March 1, 2004; 145(3): 1276 - 1283.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Takeuchi, Y. Murata, P. Sadow, Y. Hayashi, H. Seo, J. Xu, B. W. O'Malley, R. E. Weiss, and S. Refetoff
Steroid Receptor Coactivator-1 Deficiency Causes Variable Alterations in the Modulation of T3-Regulated Transcription of Genes in Vivo
Endocrinology, April 1, 2002; 143(4): 1346 - 1352.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. M. Wood, V. D. Sarapura, J. M. Dowding, W. W. Woodmansee, D. J. Haakinson, D. F. Gordon, and E. C. Ridgway
Early Gene Expression Changes Preceding Thyroid Hormone-Induced Involution of a Thyrotrope Tumor
Endocrinology, February 1, 2002; 143(2): 347 - 359.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kaneshige, K. Kaneshige, X.-g. Zhu, A. Dace, L. Garrett, T. A. Carter, R. Kazlauskaite, D. G. Pankratz, A. Wynshaw-Boris, S. Refetoff, et al.
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone
PNAS, November 2, 2000; (2000) 230285997.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. M. Staton and P. J. Leedman
Posttranscriptional Regulation of Thyrotropin {beta}-Subunit Messenger Ribonucleic Acid by Thyroid Hormone in Murine Thyrotrope Tumor Cells: A Conserved Mechanism across Species
Endocrinology, March 1, 1998; 139(3): 1093 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. D. Sarapura, H. L. Strouth, D. F. Gordon, W. M. Wood, and E. C. Ridgway
Msx1 Is Present in Thyrotropic Cells and Binds to a Consensus Site on the Glycoprotein Hormone {alpha}-Subunit Promoter
Mol. Endocrinol., November 1, 1997; 11(12): 1782 - 1794.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Bockmann, T. M. Bockers, C. Winter, W. Wittkowski, H. Winterhoff, Th. Deufel, and M. R. Kreutz
Thyrotropin Expression in Hypophyseal Pars Tuberalis-Specific Cells is 3,5,3'-Triiodothyronine, Thyrotropin-Releasing Hormone, and Pit-1 Independent
Endocrinology, March 1, 1997; 138(3): 1019 - 1028.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. A. James, V. D. Sarapura, C. Bruns, F. Raulf, J. M. Dowding, D. F. Gordon, W. M. Wood, and E. C. Ridgway
Thyroid Hormone-Induced Expression of Specific Somatostatin Receptor Subtypes Correlates with Involution of the TtT-97 Murine Thyrotrope Tumor
Endocrinology, February 1, 1997; 138(2): 719 - 724.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S K Kendall, L C Samuelson, T L Saunders, R I Wood, and S A Camper
Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice.
Genes & Dev., August 15, 1995; 9(16): 2007 - 2019.
[Abstract] [PDF]


Home page
ScienceHome page
I. Akerblom, E. Slater, M Beato, J. Baxter, and P. Mellon
Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer
Science, July 15, 1988; 241(4863): 350 - 353.
[Abstract] [PDF]


Home page
ScienceHome page
G. Uhl and S. Reppert
Suprachiasmatic nucleus vasopressin messenger RNA: circadian variation in normal and Brattleboro rats
Science, April 18, 1986; 232(4748): 390 - 393.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kaneshige, K. Kaneshige, X.-g. Zhu, A. Dace, L. Garrett, T. A. Carter, R. Kazlauskaite, D. G. Pankratz, A. Wynshaw-Boris, S. Refetoff, et al.
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone
PNAS, November 21, 2000; 97(24): 13209 - 13214.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society